Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study
同源和异源加强免疫接种ChAdOx1 nCoV-19 (COVISHIELD™) 和 BBV152 (COVAXIN®) 的免疫原性和安全性：一项非劣效性 4 期、受试者和观察者双盲、随机研究
期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2023.100141
Rose, Winsley; Raju, Reshma; Babji, Sudhir; George, Anna; Madhavan, Ramya; Leander Xavier, Julian Vivek; David Chelladurai, Jenita Sharon; Nikitha, Origanti Sharon; Deborah, Arpitha Anbu; Vijayakumar, Shalini; Immanuel, Sushil; John, Jacob; Rupali, Priscilla; Abhilash, Kundavaram P P; Mohan, Venkata Raghava; Tallapaka, Karthik Bharadwaj; Samuel, Prasanna; Kang, Gagandeep
